Medication leaflets

Active substance

Results for the substance eltrombopag

20 results shown

About this active substance

Eltrombopag is a medication used to treat thrombocytopenia, a condition characterized by a low platelet count in the blood. It is particularly indicated for patients with chronic idiopathic thrombocytopenic purpura or other conditions affecting platelet production.

This medication works by stimulating thrombopoietin receptors in the bone marrow, leading to increased platelet production. It is taken orally, usually once daily, as directed by a doctor.

Eltrombopag is generally well-tolerated but may cause side effects such as nausea, fatigue, headaches, or elevated liver enzymes. In rare cases, there may be an increased risk of blood clots.

It is important to strictly follow your doctor's recommendations and undergo regular blood tests to monitor the treatment's effects. Do not discontinue the medication without consulting a specialist.